BiotechTube
Quantum Surgical

Quantum Surgical

Montpellier, France· Est.
quantumsurgical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $100M

Overview

Quantum Surgical is a private, commercial-stage medical device company pioneering robotic-assisted solutions for interventional oncology. Its flagship product, the Epione® platform, is CE marked for abdomen, chest, and musculoskeletal procedures and FDA-cleared for abdominal ablation, designed to overcome the technical limitations of manual percutaneous ablation. With over 130 employees, installations in 15+ cancer centers, and 1,400+ patients treated globally, the company is expanding its clinical footprint and indications, recently bolstered by the strategic acquisition of NeuWave Medical. Quantum Surgical is positioned at the convergence of robotics, AI, and minimally invasive therapy to improve outcomes for patients with inoperable or challenging tumors.

Oncology

Technology Platform

Epione® robotic-assisted platform integrating a robotic arm for needle guidance, AI-powered planning software, and integrated microwave ablation technology (via NeuWave acquisition) for percutaneous tumor ablation.

Funding History

3
Total raised:$100M
Series C$50M
Series B$30M
Series A$20M

Opportunities

The underutilization of percutaneous ablation due to technical complexity presents a major addressable market for robotic standardization.
Expansion into musculoskeletal tumor ablation and the integration of acquired NeuWave technology create new revenue streams and a more complete product offering.
Growing global focus on minimally invasive, cost-effective oncology treatments aligns perfectly with the company's value proposition.

Risk Factors

Intense competition from larger, well-funded medical robotics and ablation companies poses a significant market challenge.
Achieving widespread hospital adoption requires overcoming capital budget constraints and proving a compelling return on investment.
Success is also dependent on securing favorable reimbursement codes and rates from healthcare payers in each target market.

Competitive Landscape

Quantum Surgical competes in the interventional oncology robotics space against large, diversified players like Johnson & Johnson (formerly Auris Health/Verb Surgical), Medtronic (with its Hugo RAS platform and ablation products), and Siemens Healthineers. In ablation-specific robotics, competitors include companies like XACT Robotics. The acquisition of NeuWave also positions it directly against other ablation technology leaders like Boston Scientific and AngioDynamics.

More companies in Digital Health & Biotech SaaS →More companies in France →